Home
http://www.virbac.fr/ http://www.boehringer-ingelheim.com/ http://www.novartis.com/ http://www.animalhealth.bayerhealthcare.com/
vetcontact
Vetrinär
Tiermedizin
  WELCOME  
vetcontact
Vetrinär
Tiermedizin
  Home  
  Login / Newsletter  
vetcontact
Vetrinär
Tiermedizin
  CONTACTS  
vetcontact
Vetrinär
Tiermedizin
  Classifieds  
  New Products  
  VetCompanies  
  VetSchools  
vetcontact
Vetrinär
Tiermedizin
  PROFESSION  
vetcontact
Vetrinär
Tiermedizin
  Edutainment  
  VetAgenda  
  Presentations  
  Posters  
  ESAVS  
  Specialisation  
vetcontact
Vetrinär
Tiermedizin
  INSIGHT  
vetcontact
Vetrinär
Tiermedizin
  Congress News  
  Picture Galleries  
vetcontact
Vetrinär
Tiermedizin
  PRODUCTS  
vetcontact
Vetrinär
Tiermedizin
  Bayer  
  Boehringer Ing.  
  Novartis  
  Virbac

 
  Simply book for less...  
    

Bovine    Equine    Small Animal Practice    Swine Practice    Articles    Vetjournal    
deutsch english español polski francais
Home / WELCOME / Archiv / Small Animal Practice /     
 
Prolonged remission time after pemphigus foliaceus therapy in dogs
Pemphigus foliaceus is one of the most common autoimmune diseases in dogs. Limited information is available on the long-term outcome of treatment of this disease. If life-long immunosuppressive therapy always mandatory? Interesting answers come from this study. It reports that a prolonged remission can occur after discontinuation of immunosuppressive regimens in some animals with this disease.

Six dogs were diagnosed with pemphigus foliaceus based on suggestive clinical signs and histopathology.

These patients were treated either with immunosuppressive doses of oral glucocorticoids or with a combination of oral glucocorticoids and azathioprine.

After clinical signs underwent complete remission, which occurred 1.5-5 months after immunosuppression was initiated, the drugs were tapered progressively and eventually withdrawn.

The total duration of immunosuppressive therapy varied between 3 and 22 months.

Skin lesions of pemphigus foliaceus did not recur for 1.5-6 years after treatment was stopped.

These observations suggest that, in some dogs with pemphigus foliaceus, immunosuppression can lead to long-term remission of skin lesions, and that discontinuation of treatment is not necessarily followed by a recurrence of clinical signs.



Source: Olivry T, Bergvall KE, Atlee BA. (2004): Prolonged remission after immunosuppressive therapy in six dogs with pemphigus foliaceus. In: Vet Dermatol. 2004 Aug;15(4):245-52.



Tell a friend   |   Print version   |   Send this article

SMALL ANIMAL PRACTICE

Bioavailability of suppository acetaminophen in dogsmembers
Does acetaminophen reach a satisfactory biovailability in dogs? An interesting question! This recently published study enrolling healthy and ill animals determines the plasma pharmacokinetics of suppository acetaminophen (APAP). Six healthy client‐owned and 20 clinically ill hospitalized dogs were included in this prospective study.

  • Computed tomographic lymphography for lymph node staging in dogs with malignant tumors members
  • Characterization of ocular melanosis-affected canine melanocytesmembers
  • Nasopharyngeal sialoceles in brachycephalic dogsmembers
  • Enterococcus faecium SF68 on serum cobalamin and folate concentrationsmembers
  • Gastrointestinal eosinophilic sclerosing fibroplasia limited to the mesentery in a catmembers
  • Ion acid-base disturbances and associated mortality in dogsmembers
  • First description of ultrasonic bone curette in canine otic surgerymembers
  • Staining hair samples with a modified Wright-Giemsa stain to diagnose feline dermatophytosismembers
  • Oral extended release hydrocodone as analgesia after TPLOmembers
  • 25OH vitamin D3 serum concentration in dogs with acute polyradiculoneuritismembers
  • Type 1 immune mediated polyarthritis in dogs and temporal relationship to vaccination members
  • Phosphorus and protein supply before diagnosis of chronic kidney disease members


  • [ Home ] [ About ] [ Contact / Request ][ Disclaimer ]

    Copyright © 2001-2016 VetContact GmbH
    All rights reserved